✦ LIBER ✦

One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: Results of a multicenter registry

✍ Scribed by Marcelo Sanmartin; Jose Antonio Baz; Iñigo Lozano; Jose Maria de la Torre; Jose Maria Hernandez; Pascual Bordes; Vicente Mainar; Josepa Mauri; Andrés Iñiguez

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 97 KB
Volume: 69
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.20960

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter international registry of un

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction

✍ Michael S. Lee; Dario Sillano; Azeem Latib; Alaide Chieffo; Giuseppe Biondi Zocc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

## Abstract Background: Patients who present with myocardial infarction (MI) and unprotected left main coronary artery (ULMCA) disease represent an extremely high‐risk subset of patients. ULMCA percutaneous coronary intervention (PCI) with drug‐eluting stents (DES) in MI patients has not been exten

Long-term clinical benefit of drug-eluti

Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: Results from a real-world multicenter registry

✍ Davide Capodanno; Maria Elena Di Salvo; Tullio Palmerini; Imad Sheiban; Massimo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 2 views

Predictors of restenosis after treatment

Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: A multicenter prospective registry of 150 consecutive patients

✍ Carlo Di Mario; Nuccia Morici; Cosmo Godino; Omer Goktekin; Corrado Tamburino; R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 2 views

Synergistic use of sirolimus-eluting ste

Synergistic use of sirolimus-eluting stents and intravascular ultrasound for the treatment of unprotected left main and vein graft disease

✍ Marco A. Costa; Osvaldo S. Gigliotti; Martin M. Zenni; Paul S. Gilmore; Theodore 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB 👁 2 views

Comparison of 2-year clinical outcomes w

Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: Results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry

✍ Marco Balducelli; Paolo Ortolani; Paolo Marzaroli; Giancarlo Piovaccari; Alberto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

Economic outcomes of percutaneous corona

Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: One-year results from the SYNTAX trial

✍ David J. Cohen; Tara A. Lavelle; Ben Van Hout; Haiyan Li; Yang Lei; Katherine Ro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

## Abstract Objectives: To evaluate the cost‐effectiveness of alternative approaches to revascularization for patients with three‐vessel or left main coronary artery disease (CAD). Background: Previous studies have demonstrated that, despite higher initial costs, long‐term costs with bypass surgery